Heterozygous carriers of BLM variants have not been extensively studied but there are a few studies showing mixed results with regard to cancer risk (Cleary et al., 2003; Baris et al., 2007; Antczak et al., 2013; Laitman et al., 2016; Schayek et al., 2017). This evidence concerns the gene BLM and cancer.